[Enhancement of reduction activity of 4-nitroquinoline N-oxide in rats pretreated with 3-methylcholanthrene-type PCB].
D015112:4-Nitroquinoline-1-oxide / Q000378:metabolism*; D000818:Animals; D004790:Enzyme Induction / Q000187:drug effects; D008099:Liver / Q000378:metabolism; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D009247:NADH, NADPH Oxidoreductases / Q000096:biosynthesis; D009600:Nitroquinolines / Q000378:metabolism*; D010084:Oxidation-Reduction; D011078:Polychlorinated Biphenyls / Q000633:toxicity*; D011808:Quinone Reductases / Q000096:biosynthesis; D051381:Rats; D011919:Rats, Inbred Strains
D009600:Nitroquinolines; D008748:Methylcholanthrene; D015112:4-Nitroquinoline-1-oxide; D011078:Polychlorinated Biphenyls; D009247:NADH, NADPH Oxidoreductases; D011808:Quinone Reductases; C021877:nitroquinoline N-oxide reductase